theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Rheumatology

JIA   

Questions discussed in this category


What is your approach to screening patients with sJIA for associated lung disease?
Do you universally screen? What prompts you to screen when you do? This question is part of our collaboration with ACR Convergence 2024 to Continue t...
1 Answer available

In a patient with SJIA who has been stable on Anakinra however is now planning to conceive or becomes pregnant, would you consider switching to Cimzia?
1 Answer available

Do you continue biologics in sJIA patients who develop lung disease on anti IL-1 or anti IL-6 therapies?
This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by the ...
2 Answers available

What is the risk of uveitis flare in patients with JIA and uveitis, who are in remission, when tapering medications?
1 Answer available
22032229382203315172


Papers discussed in this category


Trials, 2020 Oct 27
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.

Journal of clinical medicine, 2021 Dec 31
A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy.

Related Topics in Rheumatology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.